Tivic Health Systems Inc (TIVC NASDAQ) stock market data APIs
$1.0198
-0.02(-2%)
as of May 6, 2026
Try our APIs with
free plan!
Tivic Health Systems Inc Financial Data Overview
Price chart is built with
Anychart
Valion Bio, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Prev. Close
1.0198
Open
0.9969
High
1.0563
Low
0.946
52 wk Range
0.722-5.6
Market Cap
4 029 K
Shares Outstanding
2 878 K
Revenue
482 K
EPS
-1.97
Beta
1.844
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tivic Health Systems Inc data using free add-ons & libraries
Get Tivic Health Systems Inc Fundamental Data
Tivic Health Systems Inc Fundamental data includes:
- Net Revenue: 482 K
- EBITDA: -7 893 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Tivic Health Systems Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tivic Health Systems Inc News
New
Tivic Health outlines $20B oncology market opportunity following strategic transformation
Earnings Call Insights: Tivic Health Systems, Inc. (TIVC) Q4 2025 MANAGEMENT VIEW * Michael Handley, CEO, announced, "It is a privilege to address you for the first time as CEO of Tivic. I'm honor...
Tivic Health files to sell 1.58M shares of common stock for holders
* Tivic Health (NASDAQ:TIVC [https://seekingalpha.com/symbol/TIVC]) filed to sell 1.58 million common stock. * This prospectus is not an offer to sell these securities. * The company will not re...
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. T...
Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream
MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025. T...
Get Tivic Health Systems Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
